0001950047-23-002882.txt : 20230808
0001950047-23-002882.hdr.sgml : 20230808
20230808192806
ACCESSION NUMBER: 0001950047-23-002882
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230808
DATE AS OF CHANGE: 20230808
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: G1 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001560241
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263648180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-38096
FILM NUMBER: 231152975
BUSINESS ADDRESS:
STREET 1: 700 PARK OFFICES DRIVE
STREET 2: SUITE 200
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-213-9835
MAIL ADDRESS:
STREET 1: 700 PARK OFFICES DRIVE
STREET 2: SUITE 200
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: G-Zero Therapeutics, Inc.
DATE OF NAME CHANGE: 20121012
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Velleca Mark A.
CENTRAL INDEX KEY: 0001706847
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 79 TW ALEXANDER DRIVE
STREET 2: 4501 RESEARCH COMMONS, SUITE 100
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
144
1
primary_doc.xml
144
0001706847
XXXXXXXX
LIVE
0001560241
G1 THERAPEUTICS, INC.
001-38096
700 Park Offices Drive, Suite 200
Research Triangle Park
NC
27709
(919) 213-9835
MARK VELLECA
Director
Common
Morgan Stanley Smith Barney LLC
1 New York Plaza
38th Floor
New York
NY
10004
60000
119974.08
51745578
08/08/2023
NASD
Common
08/08/2023
Stock Option Exercise
Issuer
N
60000
08/08/2023
Cash
Y
08/08/2023
05/05/2023
/s/ Mark Albert Velleca